HydRegen Overview
- Year Founded
-
2020
- Status
-
Private
- Employees
-
18
- Latest Deal Type
-
Series A1
- Latest Deal Amount
-
$7.97M
- Investors
-
13
HydRegen General Information
Description
Developer of bio-based manufacturing technologies designed to make clean, safe, and sustainable chemicals. The company utilizes biocatalysis, which offers agility, speed, and predictability at an early stage in industrial research and development, enabling the chemicals and pharmaceutical sectors to validate that they meet critical cost, productivity, and reproducibility requirements on a large scale.
Contact Information
Website
www.hydregenoxford.comCorporate Office
- 30 Upper High Street
- Thame OX9 3EZ
- England, United Kingdom
Corporate Office
- 30 Upper High Street
- Thame OX9 3EZ
- England, United Kingdom
HydRegen Timeline
HydRegen Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Later Stage VC (Series A1) | 14-Oct-2026 | $7.97M | Completed | Generating Revenue | ||
| 5. Early Stage VC | 31-Mar-2023 | Completed | Generating Revenue | |||
| 4. Early Stage VC | 13-Jan-2022 | Completed | Generating Revenue | |||
| 3. Early Stage VC | 31-Mar-2021 | Completed | Generating Revenue | |||
| 2. Grant | 01-Feb-2021 | $573K | Completed | Generating Revenue | ||
| 1. University Spin-Out | 03-Dec-2020 | Completed | Startup |
HydRegen Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A2 Preferred | ||||||||
| Series A1 Preferred | ||||||||
| A Ordinary | ||||||||
| Ordinary | 23,432 | $0.000013 | $21.82 | $21.82 | 1x | $21.82 | 6.79% | |
| Ordinary | 21,307 | $0.000013 | $19.93 | $19.93 | 1x | $19.93 | 6.18% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
HydRegen Signals
HydRegen Investors (13)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| First Imagine! Ventures | Venture Capital | Minority | ||
| Foxglove Capital | Merchant Banking Firm | Minority | ||
| Genoa Ventures | Venture Capital | Minority | ||
| Headington Holdings | Corporation | Minority | ||
| Oxonian Investment | PE/Buyout | Minority |
HydRegen FAQs
-
When was HydRegen founded?
HydRegen was founded in 2020.
-
Where is HydRegen headquartered?
HydRegen is headquartered in Thame, United Kingdom.
-
What is the size of HydRegen?
HydRegen has 18 total employees.
-
What industry is HydRegen in?
HydRegen’s primary industry is Industrial Chemicals.
-
Is HydRegen a private or public company?
HydRegen is a Private company.
-
What is the current valuation of HydRegen?
The current valuation of HydRegen is .
-
What is HydRegen’s current revenue?
The current revenue for HydRegen is .
-
How much funding has HydRegen raised over time?
HydRegen has raised $12M.
-
Who are HydRegen’s investors?
First Imagine! Ventures, Foxglove Capital, Genoa Ventures, Headington Holdings, and Oxonian Investment are 5 of 13 investors who have invested in HydRegen.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process